Tohru Tsujimura
Impact in
- Immunology top 0.05%
- interferon and immune responses
- Immune Response and Inflammation
- Immune Cell Function and Interaction
- Mast cells and histamine
- Cancer Research top 0.5%
- NF-κB Signaling Pathways
Papers in
- Immunology 64
- Mast cells and histamine 34
- Immune Response and Inflammation 12
-
- Cell Adhesion Molecules Research 16
- Co-authors
- Shizuo AkiraOsamu TakeuchiSatoshi UematsuHiroki KatoNobuyuki TeradaShintaro SatoTaro KawaiKiyoshi Takeda
- Journals
- Blood (20 papers)Journal of Clinical Oncology (8 papers)Lung Cancer (6 papers)Nature Immunology (5 papers)Cancer Science (5 papers)
- Partner nations
- JapanUnited StatesIsrael
In The Last Decade
Tohru Tsujimura
207 papers receiving 18.2k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Immunology 9.5k
- Cancer Research 2.3k
- Hepatology 832
- Molecular Biology 7.1k
- Oncology 2.8k
Countries citing papers authored by Tohru Tsujimura
This map shows the geographic impact of Tohru Tsujimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tohru Tsujimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tohru Tsujimura more than expected).
Fields of papers citing papers by Tohru Tsujimura
This network shows the impact of papers produced by Tohru Tsujimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tohru Tsujimura. The network helps show where Tohru Tsujimura may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tohru Tsujimura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 3 | |
| 2 | 2022 | 1 | |
| 3 | 2022 | 14 | |
| 4 | 2019 | 3 | |
| 5 | 2016 | 3 | |
| 6 | 2014 | 86 | |
| 7 | 2014 | 1 | |
| 8 | 2013 | 0 | |
| 9 | 2012 | 34 | |
| 10 | 2012 | 137 | |
| 11 | LGP2 is a positive regulator of RIG-I– and MDA5-mediated antiviral responses Hit paper breakdown → | 2010 | 519 |
| 12 | 2009 | 1 | |
| 13 | 2008 | 30 | |
| 14 | 2006 | 66 | |
| 15 | 2005 | 39 | |
| 16 | 2005 | 16 | |
| 17 | 2004 | 14 | |
| 18 | 2004 | 14 | |
| 19 | 2001 | 12 | |
| 20 | [A case of liver metastasis from so-called hepatoid adenocarcinoma of stomach with lipiodol accumulation]. | 1996 | 1 |
About Tohru Tsujimura
Tohru Tsujimura is a scholar working on Immunology, Immunology and Allergy, Pulmonary and Respiratory Medicine, Hepatology and Cancer Research, having authored 213 papers that have together received 18.4k indexed citations. Recurring topics across this work include Occupational and environmental lung diseases (47 papers), Mast cells and histamine (34 papers), Pleural and Pulmonary Diseases (33 papers), Medical Imaging and Pathology Studies (27 papers), Cell Adhesion Molecules Research (16 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (15 papers), Immune Response and Inflammation (12 papers) and DNA Repair Mechanisms (11 papers). The work is most often cited by research in Immunology (9.5k citations), Cancer Research (2.3k citations), Hepatology (832 citations), Molecular Biology (7.1k citations) and Oncology (2.8k citations). Tohru Tsujimura has collaborated with scholars based in Japan, United States and Israel. Frequent co-authors include Shizuo Akira, Osamu Takeuchi, Satoshi Uematsu, Hiroki Kato, Nobuyuki Terada, Shintaro Sato, Taro Kawai, Kiyoshi Takeda, Takashi Fujita and Mitsutoshi Yoneyama. Their work appears in journals such as Blood, Journal of Clinical Oncology, Lung Cancer, Nature Immunology and Cancer Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.